Essential components of effective HIV care: A policy paper of the HIV medicine association of the infectious diseases society of america and the ryan white medical providers coalition

Clinical Infectious Diseases

Volumn 53, Issue 11, 2011, Pages 1043-1050

  Gallant, Joel E ^a   Adimora, Adaora A ^b   Carmichael, J Kevin ^c   Horberg, Michael ^d   Kitahata, Mari ^e   Quinlivan, E Byrd ^b   Raper, James L ^f   Selwyn, Peter ^g   Williams, Steven Bruce ^h  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c Special Immunology Associates Clinic   (United States)

^d Mid Atlantic Permanente Research Institute   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CD4 LYMPHOCYTE COUNT; CHLAMYDIA; CLINICAL COMPETENCE; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; ELECTRONIC MEDICAL RECORD; EPIDEMIC; EVOLUTION; FUNDING; GONORRHEA; HEALTH CARE ACCESS; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEPATITIS B; HEPATITIS C; HIGH RISK BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RATE; INFLUENZA VACCINATION; INTRAVENOUS DRUG ABUSE; MEDICAID; MEDICAL CARE; MEDICAL SOCIETY; PNEUMOCOCCAL INFECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH; QUALITY CONTROL; RISK REDUCTION; SCREENING; SEROLOGY; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; TUBERCULOSIS;

HEALTH POLICY; HIV INFECTIONS; HUMANS; UNITED STATES;

EID: 80855133368     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir689     Document Type: Article

References (61)

1. Losina E, Schackman Bruce R, Sadownik Sara N, et al. Racial and sex disparities in life expectancy losses among HIV-infected persons in the United States: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy. Clin Infect Dis 2009;49:1570-8.
2. Saag MS. Ryan White: an unintentional home builder. AIDS Read 2009;19:166-8.
3. Walensky RP, Paltiel AD, Losina E, et al. The survival benefits of AIDS treatment in the United States. J Infect Dis 2006;194:11-9.
4. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. New Engl J Med 2011;365:493-505.
5. Ryan White Comprehensive AIDS Resources Emergency (CARE) Act, Pub. L. 101-381, 104 Stat. 576. 1990.
6. The Henry J. Kaiser Family Foundation. Fact sheet: Medicaid and HIV/AIDS: Kaiser Family Foundation, 2009.
7. National HIV/AIDS strategy for the United States. In: The White House Office of National AIDS Policy: The White House, 2010.
8. The Patient Protection and Affordable Care Act, Pub. L. 111-148, 124 Stat. 119-1024, 2010.
9. Health Care and Education Reconciliation Act of 2010, Pub. L. 111-152, 124 Stat. 1029-124, Stat. 1084, 2011.
10. Kitahata MM, Gange SJ, Abraham AG, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. New Engl J Med 2009;360:1815-26.
11. Gardner LI, Metsch LR, Anderson-Mahoney P, et al. Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS 2005;19:423-31. (Pubitemid 40446189)
12. Reed BJ, Hanson D, McNaghten A, et al. HIV testing factors associated with delayed entry into HIV medical care among HIV-infected persons from eighteen states, United States, 2000-2004. AIDS Patient Care STDs 2009;23:765-73.
13. Horberg MA, Hurley L, Towner W, et al. HIV quality performance measures in a large integrated health care system. AIDS Patient Care STDs 2011;25:21-8.
14. Institutes of Medicine. Public financing and delivery of HIV/AIDS care: securing the legacy of Ryan White: National Academies Press, 2004.
15. Fleming P, Byers R. HIV prevalence in the United States, 2000. Program and abstracts of the 7th Conference on Retroviruses and Opportunistic Infections;San Francisco. Alexandria, VA: CROI, 2000. Abstract 11.
16. Teshale E. Estimated number of HIV-infected persons eligible for and receiving HIV antiretroviral therapy, 2003-United States. Program and abstracts of the 12th Conference on Retroviruses and Opportunistic Infections;Boston. Alexandria, VA: CROI, 2005. Abstract 167.
17. Mugavero MJ, Lin H-Y, Allison JJ, et al. Racial disparities in HIV virologic failure: do missed visits matter? J Aquir Immune Defic Syndr 2009;50:100-8.
18. Gardner EM, McLees MP, Steiner JF, del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis 2011;52:793-800.
19. Sherer R, Stieglitz K, Narra J, et al. HIV multidisciplinary teams work: support services improve access to and retention in HIV primary care. AIDS Care 2002;14(Suppl 1):S31-44.
20. Sherer R. Adherence and antiretroviral therapy in injection drug users. JAMA 1998;280:567-8. (Pubitemid 28377681)
21. Veterans Health Administration. The state of care for veterans with HIV/AIDS: Department of Veterans Affairs, 2009.
22. Hoang T, Goetz MB, Yano EM, et al. The impact of integrated HIV care on patient health outcomes. Med Care 2009;47:560-7.
23. Golin CE, Smith SR, Reif S. Adherence counseling practices of generalist and specialist physicians caring for people living with HIV/AIDS in North Carolina. J Gen Intern Med 2004;19:16-27. (Pubitemid 38221947)
24. Geletko S, Poulakos M. Pharmaceutical services in an HIV clinic. Am J Health Syst Pharm 2002;59:709-13. (Pubitemid 34407154)
25. Rathburn CR, Farmer KC, Stephens JR, Lockhart SM. Impact of an adherence clinic on behavioral outcomes and virologic response in the treatment of HIV infection: a prospective, randomized, controlled pilot study. Clin Ther 2005;27:199-209. (Pubitemid 40462013)
26. Horberg MA, Hurley LB, Silverberg MJ, Kinsman CJ, Quesenberry CP. Effect of clinical pharmacists on utilization of and clinical response to antiretroviral therapy. J Aquir Immune Defic Syndr 2007;44:531-9. (Pubitemid 46594896)
27. Bonnet F, Burty C, Lewden C, et al. Changes in cancer mortality among HIV-infected patients: the Mortalité2005 Survey. Clin Infect Dis 2009;48:633-9.
28. Taylor LE, Holubar M, Wu K, et al. Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials. Clin Infect Dis 2011;52:812-8.
29. Ledergerber B, Furrer H, Rickenbach M, et al. Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study. Clin Infect Dis 2007;45:111-9. (Pubitemid 46984626)
30. Fedele F, Bruno N, Mancone M. Cardiovascular risk factors and HIV disease. AIDS Rev 2011;13:119-29.
31. Kirk GD, Merlo C, O'Driscoll P, et al. HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis 2007;45:103-10. (Pubitemid 46984625)
32. Freiberg MS, Chang CC, Skanderson M, et al. The risk of incident coronary heart disease among veterans with and without HIV and hepatitis C. Circ Cardiovasc Qual Outcomes 2011;4:425-32.
33. Gaynes BN, Pence BW, Eron JJ, Miller WC. Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV1 patient population. Psychosom Med 2008;70:505-11.
34. Health Resources and Services Administration. HIV Early Intervention Services (EIS) program: Department of Health &Human Services, 2011.
35. Kitahata MM, Koepsell TD, Deyo RA, Maxwell CL, Dodge WT, Wagner EH. Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival. New Engl J Med 1996;334:701-7.
36. Landon BE, Wilson IB, Cohn SE, et al. Physician specialization and antiretroviral therapy for HIV. J Gen Intern Med 2003;18:233-41.
37. Wilson IB, Landon BE, Hirschhorn LR, et al. Quality of HIV care provided by nurse practitioners, physician assistants, and physicians. Ann Intern Med 2005;143:729-36.
38. Bozzette SA, Joyce G, McCaffrey DF, et al. Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy. New Engl J Med 2001;344:817-23. (Pubitemid 32222161)
39. HIV/AIDS Nursing Certification Board. ACRN Certification. Available at: http://www.hancb.org/. Accessed 15 June 2011.
40. Services With Special Circumstances. Arizona Health Care Cost Containment System medical policy manual. Vol 320: Arizona Health Care Cost Containment System (AHCCCS), 2009:1-37.
41. California Department of Managed Health Care. Knox-Keene Health Care Service Plan Act of 1975. Available at: http://wpso.dmhc.ca.gov/regulations/ 10kkap/10kkap.htm. Accessed 15 June 2011.
42. Hauschild BC, Weddle A, Lubinski C, Tegelvik JT, Miller V, Saag MS. HIV clinic capacity and medical workforce challenges: results of a survey of Ryan White part C-funded programs. Annals of the Forum for Collaborative HIV Research 2011;13:1-9.
43. Gallant JE. What does the generalist need to know about HIV infection? Adv Chronic Kidney Dis 2010;17:5-18.
44. Slatore CG, Cecere LM, Reinke LF, et al. Patient-clinician communication: associations with important health outcomes among veterans with COPD. Chest 2010;138:628-34.
45. Bennett HD, Coleman EA, Parry C, Bodenheimer T, Chen EH. Health coaching for patients with chronic illness. Fam Pract Manag 2010;17:24-9.
46. Saha S, Jacobs EA, Moore RD, Beach MC. Trust in physicians and racial disparities in HIV care. AIDS Patient Care STDs 2010;24:415-20.
47. Campo RE, Narayanan S, Clay PG, et al. Factors influencing the acceptance of changes in antiretroviral therapy among HIV-1-infected patients. AIDS Patient Care STDs 2007;21:329-38. (Pubitemid 46842160)
48. Volkmann ER, Claiborne D, Currier JS. Determinants of participation in HIV clinical trials: the importance of patients' trust in their provider. HIV Clin Trials 2009;10:104-9.
49. Backus LI, Boothroyd DB, Phillips BR, et al. National quality forum performance measures for HIV/AIDS care: the Department of Veterans Affairs' experience. Arch Intern Med 2010;170:1239-46.
50. Horberg Michael A, Aberg Judith A, Cheever Laura W, Renner P, O'Brien Kaleba E, Asch Steven M. Development of national and multiagency HIV care quality measures. Clin Infect Dis 2010;51:732-8.
51. HIVQUAL-US. How HIVQUAL Works Available at: http://hivqualus. org/. Accessed 15 June 2011.
52. Centers for Medicare &Medicaid Services. Physician quality reporting system. Available at: https://www.cms.gov/PQRS/. Accessed 15 June 2011.
53. Centers for Medicare &Medicaid Services. EHR incentive programs. Available at: https://www.cms.gov/ehrincentiveprograms/. Accessed 15 June 2011.
54. Centers for Medicare &Medicaid Services. Health homes for enrollees with chronic conditions: Department of Health&Human Services, 2010.
55. Zuckerman S, Williams AF, Stockley KE. Trends in Medicaid physician fees, 2003-2008. Health Aff (Millwood) 2009;28:w510-w19.
56. Shapiro MF, Morton SC, McCaffrey DF, et al. Variations in the care of HIV-infected adults in the United States. JAMA 1999;281:2305-15.
57. Agency for Healthcare Research and Quality. Health care coverage analyses of the 2006 national healthcare quality and disparities reports. Baltimore: Centers for Medicare &Medicaid Services, 2008.
58. Chen RY, Accortt NA, Westfall AO, et al. Distribution of health care expenditures forHIV-infected patients. Clin Infect Dis 2006;42:1003-10.
59. Kitahata MM, Holmes KK, Wagner EH, Gooding TD. Caring for persons with HIV infection in a managed care environment. Am J Med 1998;104:511-6.
60. Feldman I. Changing Medicaid Reimbursement Models for HIV/AIDS in New York State. In: National summit on HIV diagnosis, prevention and Access to Care: The Forum for Collaborative HIV Research, 2010.
61. Yehia BR, Fleishman JA, Hicks PL, Ridore M, Moore RD, Gebo KA. Inpatient health services utilization among HIV-infected adult patients in care 2002-2007. J Acquir Immune Defic Syndr 2010;53:397-404.